Compare Manchester United PLC (MANU) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manchester United PLC vs McKesson Corporation — how do they compare? Manchester United PLC trades at $22.08 (market cap $3.80B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 25.6× Manchester United PLC's market cap, and Manchester United PLC pays the higher dividend (1.26%). Which is the better fit depends on your goals.
| MANU | MCK | |
|---|---|---|
Market Cap | $3.80B | $97.35B |
Sector | Media | Health |
52-Week High | $23.53 | $995.69 |
52-Week Low | $15.10 | $659.01 |
Enterprise Value | $4.72B | $101.98B |
Dividend Yield | 1.26% | 0.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manchester United (MANU) trades at $22.45, up 0.99% on the day, with a neutral technical signal and mixed earnings performance. The company reported a net loss of $33.02M for 2025, though revenue grew to $666.51M. Recent news highlights progress on a new 100,000-seat stadium and Champions League qualification, which may boost future revenue. The stock's valuation shows a P/S of 4.21 and negative ROE of -6.36%, reflecting profitability challenges amid strategic investments.
The outlook is cautiously optimistic, driven by stadium development and sports performance, but high debt and inconsistent earnings pose risks. Analysts are mixed with 40% buy ratings. Investors should weigh growth initiatives against financial leverage and margin pressures.
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
